aspirin and pentachlorophenol

aspirin has been researched along with pentachlorophenol in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Arnout, J; Herbert, JM; Meuleman, DG; Pislaru, C; Pislaru, SV; Stassen, T; Van de Werf, F; Vanhove, P; Zhu, X	1
Bassand, JP; Cariou, R; Claudel, S; Donat, F; Fontecave, S; Meneveau, N; Samama, MM; Schiele, F; Vuillemenot, A	1
Bassand, JP	1

Reviews

1 review(s) available for aspirin and pentachlorophenol

Article	Year
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease. Haemostasis, 2000, Volume: 30 Suppl 2 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2000

Article

Year

Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.

Haemostasis, 2000, Volume: 30 Suppl 2

Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2000

Trials

1 trial(s) available for aspirin and pentachlorophenol

Article	Year
Efficacy of a synthetic pentasaccharide, a pure factor Xa inhibitor, as an antithrombotic agent--a pilot study in the setting of coronary angioplasty. Thrombosis and haemostasis, 1999, Volume: 81, Issue:2 Topics: Adolescent; Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Oligosaccharides; Pilot Projects; Platelet Aggregation Inhibitors; Premedication; Treatment Outcome	1999

Article

Year

Efficacy of a synthetic pentasaccharide, a pure factor Xa inhibitor, as an antithrombotic agent--a pilot study in the setting of coronary angioplasty.

Thrombosis and haemostasis, 1999, Volume: 81, Issue:2

Topics: Adolescent; Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Oligosaccharides; Pilot Projects; Platelet Aggregation Inhibitors; Premedication; Treatment Outcome

1999

Other Studies

2 other study(ies) available for aspirin and pentachlorophenol

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysis. Thrombosis and haemostasis, 1998, Volume: 79, Issue:6 Topics: Animals; Anticoagulants; Antithrombin III; Aspirin; Bleeding Time; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrinolytic Agents; Hemostasis; Heparin; Oligosaccharides; Partial Thromboplastin Time; Random Allocation; Thrombolytic Therapy; Tissue Plasminogen Activator	1998

Article

Year

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008

Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysis.

Thrombosis and haemostasis, 1998, Volume: 79, Issue:6

Topics: Animals; Anticoagulants; Antithrombin III; Aspirin; Bleeding Time; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrinolytic Agents; Hemostasis; Heparin; Oligosaccharides; Partial Thromboplastin Time; Random Allocation; Thrombolytic Therapy; Tissue Plasminogen Activator

1998